Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study.

Adaptive screening schedules can reduce the associated harms of screening while maintaining its associated lung cancer mortality reductions and years of life gained. Our study identifies individually tailored schedules that optimize the screening benefit/harm trade-offs.